跳至主要内容
临床试验/ISRCTN15121154
ISRCTN15121154进行中(未招募)未知

A retrospective, non-interventional, chart review study of the effectiveness of FreeStyle Libre in adults with type 2 diabetes

Abbott (United Kingdom) Diabetes Care Ltd0 个研究点目标入组 78 人开始时间: 2022年10月3日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
78

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • 1. Age 18 years or over
  • 2. Has type 2 diabetes using basal-bolus insulin regimen for at least 1 year
  • 3. Has used FreeStyle Libre/Libre 2 regularly for at least 3 months
  • 4. HbA1c recorded in medical notes between 8.0% and 12.0% (64 to 108 mmol/mol) in the 3 months prior to starting FreeStyle Libre/Libre 2
  • 5. HbA1c recorded in medical notes 3 to 6 months after starting FreeStyle Libre/Libre 2

排除标准

  • 1. Female participant who was pregnant during the data collection period
  • 2. Received dialysis treatment during the data collection period
  • 3. Participated in another device or drug study that could have affected glucose measurements or management during the data collection period

研究者

发起方
Abbott (United Kingdom) Diabetes Care Ltd

相似试验